- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Verona Pharma PLC ADR is a biotechnology business based in the US. Verona Pharma PLC ADR shares (VRNA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $42.02 – an increase of 1.45% over the previous week. Verona Pharma PLC ADR employs 79 staff and has a trailing 12-month revenue of around $5.6 million.
Our top picks for where to buy Verona Pharma PLC ADR stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Verona Pharma PLC ADR stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – VRNA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Verona Pharma PLC ADR stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Verona Pharma PLC ADR stock price (NASDAQ: VRNA)
Use our graph to track the performance of VRNA stocks over time.Verona Pharma PLC ADR shares at a glance
Information last updated 2024-12-19.
| Latest market close | $42.02 |
|---|---|
| 52-week range | $11.39 - $43.73 |
| 50-day moving average | $37.00 |
| 200-day moving average | $23.94 |
| Wall St. target price | $47.29 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-2.00 |
Is it a good time to buy Verona Pharma PLC ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Verona Pharma PLC ADR price performance over time
Historical closes compared with the close of $42.02 from 2024-12-20
| 1 week (2024-12-13) | 1.45% |
|---|---|
| 1 month (2024-11-22) | 8.27% |
| 3 months (2024-09-20) | 40.11% |
| 6 months (2024-06-21) | 180.13% |
| 1 year (2023-12-22) | 139.29% |
|---|---|
| 2 years (2022-12-22) | 90.57% |
| 3 years (2021-12-22) | 600.33% |
| 5 years (2019-12-20) | 846.57% |
Verona Pharma PLC ADR financials
| Revenue TTM | $5.6 million |
|---|---|
| Gross profit TTM | $112,000 |
| Return on assets TTM | -28.05% |
| Return on equity TTM | -78.03% |
| Profit margin | 0% |
| Book value | $1.60 |
| Market Capitalization | $3.3 billion |
TTM: trailing 12 months
Verona Pharma PLC ADR share dividends
We're not expecting Verona Pharma PLC ADR to pay a dividend over the next 12 months.
Verona Pharma PLC ADR share price volatility
Over the last 12 months, Verona Pharma PLC ADR's shares have ranged in value from as little as $11.39 up to $43.73. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Verona Pharma PLC ADR's is 0.424. This would suggest that Verona Pharma PLC ADR's shares are less volatile than average (for this exchange).
Verona Pharma PLC ADR overview
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom. .
Frequently asked questions
What percentage of Verona Pharma PLC ADR is owned by insiders or institutions?Currently 1.85% of Verona Pharma PLC ADR shares are held by insiders and 89.093% by institutions. How many people work for Verona Pharma PLC ADR?
Latest data suggests 79 work at Verona Pharma PLC ADR. When does the fiscal year end for Verona Pharma PLC ADR?
Verona Pharma PLC ADR's fiscal year ends in December. Where is Verona Pharma PLC ADR based?
Verona Pharma PLC ADR's address is: 3 More London Riverside, London, United Kingdom, SE1 2RE What is Verona Pharma PLC ADR's ISIN number?
Verona Pharma PLC ADR's international securities identification number is: US9250501064 What is Verona Pharma PLC ADR's CUSIP number?
Verona Pharma PLC ADR's Committee on Uniform Securities Identification Procedures number is: 925050106
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question